Bayer said its eye treatment aflibercept showed positive results in a late-stage trial, including improved vision gains for people suffering from some retinal diseases.
Related Posts
Henkel Backs Guidance After Sales Rise
The German chemical and consumer-goods company, which owns brands including Persil and Schwarzkopf, reported higher sales and backed expectations for the year.
Standard General Agrees to Buy Out Bally
Hedge fund Standard General agreed to buy the balance of shares in casino chain Bally’s in a deal that values the firm at about $4.6 […]
Boeing Warns on Cash Burn, Awaits Strike Vote
The jet maker posted its biggest quarterly loss since 2020. CEO Kelly Ortberg said the jet maker needs a culture change and a deal with […]